On April 1, 2010
Myriad Fallout: Who Are the Winners and Losers in the Gene Patent Ruling?
If the recent federal court ruling in the Myriad Genetics (MYGN) case — which invalidated gene patents based on isolated chunks of DNA — holds up on appeal, it will hurt any company whose drugs are based on isolating or
…
0 Comments